2022
DOI: 10.1016/j.cardfail.2022.07.047
|View full text |Cite
|
Sign up to set email alerts
|

Guideline-Directed Medical Therapy in Newly Diagnosed Heart Failure With Reduced Ejection Fraction in the Community

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…According to the results of recently published data and our analysis, HFOC greatly impacts the implementation and continuous optimisation of novel GDMT [38,39]. A recently published cohort study by Dunlay et al revealed that care at an HF clinic is independently associated with the initiation of new first-line HFrEF drugs (referring to all conventional neurohormonal antagonist therapies) among de novo HFrEF patients, leading to a 1.54-2.49-fold increase in their implementation [39]. In our patient cohort, HFOC resulted in a significantly higher application rate of triple therapy at 1 year, and the number of patients at target doses of triple therapy also exceeded that in the non-HFOC group.…”
Section: Impact Of Heart Failure Outpatient Care On the Application O...mentioning
confidence: 86%
See 1 more Smart Citation
“…According to the results of recently published data and our analysis, HFOC greatly impacts the implementation and continuous optimisation of novel GDMT [38,39]. A recently published cohort study by Dunlay et al revealed that care at an HF clinic is independently associated with the initiation of new first-line HFrEF drugs (referring to all conventional neurohormonal antagonist therapies) among de novo HFrEF patients, leading to a 1.54-2.49-fold increase in their implementation [39]. In our patient cohort, HFOC resulted in a significantly higher application rate of triple therapy at 1 year, and the number of patients at target doses of triple therapy also exceeded that in the non-HFOC group.…”
Section: Impact Of Heart Failure Outpatient Care On the Application O...mentioning
confidence: 86%
“…Despite this, it must be highlighted that these studies referred to stable patients already receiving GDMT and showing no signs of worsening heart failure. Moreover, the former were published before the results of the latest RCTs which have reformed the complex pharmacotherapy of HFrEF, and it is a well-known fact that HF outpatient care has a huge impact on the implementation and long-term application of novel GDMT [38,39]. Based on the disease's progressive nature [53], the regular revision of drug and device options and the need for advanced HF therapies is essential.…”
Section: Heart Failure Outpatient Care and The Prognosis Of Hfrefmentioning
confidence: 99%
“…Regarding follow-up structure, most participants schedule visits once a year, more often for patients with HFrEF, which might be linked to the higher number of therapeutical options available in this HF phenotype, the need of GDMT up-titration and the changing clinical profile over time which might trigger dose modification ( 19 , 20 ). Nurse-led HF clinics, currently mainly available in a secondary/tertiary care, are considered by most as an optimal setting for following HF patients and an excellent environment for up-titrating medications ( 21 , 22 ).…”
Section: Discussionmentioning
confidence: 99%
“…In clinical practice, a gap remains in implementing recommendations for optimizing GDMT for heart failure with reduced ejection fraction (HFrEF), defined as HF with an ejection fraction ≤40% [ 1 , 2 ]. This is due to multiple factors such as a variable patient profile, co-morbidities, difficulty of timely patient follow-up, and the increasing complexity of the treatment regimen [ 3 ].…”
Section: Introductionmentioning
confidence: 99%